Organon Ebit from 2010 to 2026

OGN Stock  USD 7.39  0.33  4.67%   
Organon EBIT yearly trend continues to be very stable with very little volatility. EBIT is likely to grow to about 1.7 B this year. During the period from 2010 to 2026, Organon EBIT quarterly data regression pattern had sample variance of 674453.4 T and median of  3,106,000,000. View All Fundamentals
 
EBIT  
First Reported
2020-03-31
Previous Quarter
371 M
Current Value
235 M
Quarterly Volatility
167.3 M
 
Covid
 
Interest Hikes
Check Organon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organon's main balance sheet or income statement drivers, such as Depreciation And Amortization of 481.4 M, Interest Expense of 282.2 M or Selling General Administrative of 1.2 B, as well as many indicators such as Price To Sales Ratio of 0.28, Dividend Yield of 0.0423 or PTB Ratio of 2.16. Organon financial statements analysis is a perfect complement when working with Organon Valuation or Volatility modules.
  
Build AI portfolio with Organon Stock
Check out the analysis of Organon Correlation against competitors.
Evaluating Organon's Ebit across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Organon Co's fundamental strength.

Latest Organon's Ebit Growth Pattern

Below is the plot of the Ebit of Organon Co over the last few years. It is Organon's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Organon's overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Slightly volatile
   Ebit   
       Timeline  

Organon Ebit Regression Statistics

Arithmetic Mean2,519,185,621
Geometric Mean2,367,665,574
Coefficient Of Variation32.60
Mean Deviation735,406,844
Median3,106,000,000
Standard Deviation821,251,110
Sample Variance674453.4T
Range2.4B
R-Value(0.82)
Mean Square Error237677.4T
R-Squared0.67
Significance0.000059
Slope(133,082,734)
Total Sum of Squares10791254.2T

Organon Ebit History

20261.7 B
20251.3 B
20241.3 B
20231.2 B
20221.5 B
20211.8 B
20202.8 B

Other Fundumenentals of Organon

About Organon Financial Statements

Organon investors utilize fundamental indicators, such as Ebit, to predict how Organon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
EBIT1.3 B1.7 B
EBITDA1.6 B2.2 B
Ebt Per Ebit 0.33  0.31 
Ebit Per Revenue 0.21  0.34 

Pair Trading with Organon

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will appreciate offsetting losses from the drop in the long position's value.

Moving against Organon Stock

  0.3721P Aurora CannabisPairCorr
  0.32WEED Canopy Growth CorpPairCorr
  0.31KG Kestrel Group Symbol ChangePairCorr
The ability to find closely correlated positions to Organon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organon Co to buy it.
The correlation of Organon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:
Check out the analysis of Organon Correlation against competitors.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Will Pharmaceuticals sector continue expanding? Could Organon diversify its offerings? Factors like these will boost the valuation of Organon. Anticipated expansion of Organon directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Organon data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.56)
Dividend Share
0.34
Earnings Share
0.72
Revenue Per Share
23.954
Quarterly Revenue Growth
(0.05)
Investors evaluate Organon using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Organon's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Organon's market price to deviate significantly from intrinsic value.
It's important to distinguish between Organon's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Organon should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Organon's market price signifies the transaction level at which participants voluntarily complete trades.